Recently, Qianjiang Yong'an Pharmaceutical Co., Ltd. was granted an invention patent certificate by the State Intellectual Property Office for "A Method for Simultaneously Preparing Taurine, Methyltaurate, and Methyltaurate" (Chinese Invention Patent, Patent No.: ZL202310990015.6). This patent further solidifies the company's independent intellectual property rights in the taurine field, injecting strong momentum into the company's development within the industry.
As a core enterprise in the taurine field, Yong'an Pharmaceutical has always taken technological innovation as its core engine, continuously deepening its research and development in taurine production processes and technologies.
This invention patent achieves process innovation for the simultaneous preparation of multiple high-value products, not only improving production efficiency and product quality but also strengthening the company's core technological barriers, effectively protecting independent intellectual property rights, enhancing core competitiveness, and helping taurine products continuously enhance their brand influence in the international market.
Throughout its journey, innovation and intellectual property have become the distinctive features of Yong'an Pharmaceutical's high-quality development.
To date, the company holds over 50 authorized taurine patents, including 39 invention patents covering major markets such as China, the United States, Europe, Japan, and Indonesia, forming a comprehensive international intellectual property protection system.
The company comprehensively promotes the construction of the entire chain of intellectual property creation, utilization, protection, and management, strengthens the protection of trade secrets, and ensures that intellectual property truly becomes a "key weapon" for participating in market competition, providing a solid guarantee for the company's sustainable development.
Intellectual property is the lifeline of an enterprise and a direct manifestation of its core competitiveness.
In the future, Yong'an Pharmaceutical will continue to use independent innovation as its engine, continuously increase R&D investment, deepen technological breakthroughs, and constantly improve its intellectual property strategic layout. It will transform more innovative achievements into market advantages, continuously consolidate its technological and market advantages in the taurine field, empower the industry with technology, protect development with patents, and contribute to the high-quality development of the industry.
Mobile: +8615380400285
E-mail: sales2@liwei-chem.com
Website: www.yongan-pharmaceutical.com
